Referred patients without residual tumour (n=33) | Referred patients with residual tumour (n=38) | p-value | Statistical test | |
---|---|---|---|---|
Demographics | Students t test | |||
Male | 57.8% | 49.0% | 0.391 | |
Female | 42.2% | 51.0% | ||
Under 50 years of age | 75.6% | 58.8% | 0.083 | |
50 years of age and older | 24.4% | 41.2% | ||
Median age | 57.24 | 54.78 | 0.523 | |
Clinical data | ||||
FNCLCC grade | Chi2 test | |||
Low | 29.3% | 18.2% | 0.483 | |
Intermediate | 36.6% | 43.2% | ||
High | 34.1% | 38.6% | ||
Tumour size | Chi2 test | |||
Size ≤ 5 cm (T1) | 48.8% | 54.5% | 0.595 | |
Size > 5 cm (T2) | 51.2% | 45.5% | ||
Tumour location with reference to fascia | Chi2 test | |||
Superficial (Ta) | 39.0% | 29.5% | 0.357 | |
Deep (Tb) | 61.0% | 70.5% | ||
NCCN stage | Chi2 test | |||
IA | 17.1% | 9.1% | 0.146 | |
IB | 17.1% | 11.4% | ||
IIA | 34.1% | 47.7% | ||
IIB | 9.8% | 15.9% | ||
III | 22.0% | 9.1% | ||
IV | 0.0% | 6.8% | ||
Histopathological diagnosis | Chi2 test | |||
Liposarcoma | 37.8% | 27.5% | 0.861 | |
Leiomyosarcoma | 6.7% | 7.8% | ||
Rhabdomyosarcoma | 2.2% | 3.9% | ||
Synovial sarcoma | 6.7% | 7.8% | ||
Malignant fibrous histiocytoma | 22.2% | 15.7% | ||
Fibrosarcoma | 11.1% | 11.8% | ||
Other | 13.30% | 25.50% | ||
Location | Chi2 test | |||
Upper extremity | 17.8% | 41.2% | 0.001 | |
Lower extremity | 62.2% | 33.3% | ||
Head and neck | 8.9% | 0.0% | ||
Trunk | 11.1% | 25.5% |